SCHEMBL5350206

SCHEMBL5350206

O=C(O)c1csc2c1CCCC2=NO

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.38
CHEK1 O14757 1/20 0.36
AURKA O14965 1/20 0.36
DAPK3 O43293 1/20 0.36
PRKD3 O94806 1/20 0.36
MAP4K4 O95819 1/20 0.36
ABL1 P00519 1/20 0.36
NTRK1 P04629 1/20 0.36
RET P07949 1/20 0.36
MET P08581 1/20 0.36
PIM1 P11309 1/20 0.36
FGFR1 P11362 1/20 0.36
PDGFRA P16234 1/20 0.36
PRKACA P17612 1/20 0.36
FLT1 P17948 1/20 0.36
LTK P29376 1/20 0.36
GRK5 P34947 1/20 0.36
MAPK8 P45983 1/20 0.36
CSNK1A1 P48729 1/20 0.36
CDK8 P49336 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5350197 1.00 POLB (0.38) POLBCHEK1AURKADAPK3PRKD3
SCHEMBL5351010 0.83 FABP4 (0.38) POLBHPGDALDH1A1NPSR1MAPT
SCHEMBL5354228 0.80 HPGD (0.33) HPGDALDH1A1HTTMAPTSMN1; SMN2
SCHEMBL5354233 0.80 HPGD (0.33) HPGDALDH1A1HTTMAPTSMN1; SMN2
SCHEMBL5355924 0.79 HPGD (0.61) HPGDALDH1A1TSHRHTTL3MBTL1
SCHEMBL5361096 0.79 HPGD (0.46) HPGDALDH1A1HTTMAPTSMN1; SMN2
SCHEMBL14341897 0.79 SMN1; SMN2 (0.44) POLBHPGDALDH1A1USP2TSHR
SCHEMBL5361080 0.79 HPGD (0.46) HPGDALDH1A1HTTMAPTSMN1; SMN2
SCHEMBL5355920 0.79 HPGD (0.61) HPGDALDH1A1TSHRHTTL3MBTL1
SCHEMBL5355928 0.78 MAPK8 (0.42) POLBCHEK1AURKADAPK3PRKD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7217723-B2 Substituted benzothiophenes, e.g., 7Z)-7-hydroxyimino-4,5,6,7-tetrahydro-benzo[b]thiophene-3-sulfonic acid [2-(4-fluorophenyl)-2-hydroxyethyl]-methyl-amide; treating allergies such as atopic dermatitis, allergic coryza, bronchial asthma, hypersensitive pneumoniac and pulmonary aspergillosis. EISAI CO., LTD. (JP) 2007-05-15 US disclosed
US-20050227959-A1 Heterocyclic compound having oxime group EISAI CO., LTD. (JP) 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050227959-A1 Heterocyclic compound having oxime group STAT6, HRH4, HRH2 POLB 4113/4885CHEK1 3396/4885AURKA 2780/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.